封面
市場調查報告書
商品編碼
1694792

2025年照護現場(POC)血液凝固檢驗市場報告

Point-of-Care (POC) Coagulation Testing Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

由於心血管疾病 (CVD) 盛行率不斷上升,預計照護現場(POC)血液凝固檢驗市場將會成長。 CVD包括影響心臟和血管的多種疾病,例如冠狀動脈疾病和腦血管疾病。 POC血液凝固檢驗在 CVD 治療中發揮重要作用,它提供有關凝血狀態的即時訊息,能夠及時干預並降低出血併發症的風險,尤其是在心血管手術後。例如,2023年美國,美國疾病管制與預防中心報告稱,2021年心臟病將在美國奪走約69.5萬人的生命,佔每五人死亡中的一人。心臟疾病,2021 年導致 375,476 人死亡。心血管疾病盛行率的不斷上升是支持 POC血液凝固檢驗市場成長的關鍵因素。

照護現場(POC)血液凝固檢驗市場的主要企業正專注於策略聯盟以加強其競爭地位。此類聯盟涉及兩方或多方之間為實現特定的、互惠互利的目標而達成的正式協議。例如,2021年10月,Trivitron Healthcare與Diagon Ltd.和Vanguard Diagnostics合作推出了一款凝血分析儀產品。這些分析儀提供準確、高效的血液凝固檢驗,此次合作旨在加強患者的診斷和管理。它專為在各種醫療保健環境中使用而設計,使血液凝固檢驗更加容易進行。

2023年12月,瑞士製藥公司羅氏以3.5億美元收購了Lumiradex。此次收購增強了羅氏的診斷產品組合,透過涵蓋整個病人歷程的即時護理解決方案實現更加以患者為中心的醫療保健。總部位於英國的 Lumiradex 專門照護現場血液凝固檢驗。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場-宏觀經濟情景,包括利率、通膨、地緣政治、新冠疫情、以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球照護現場(POC)血液凝固檢驗PESTEL 分析(政治、社會、技術、環境、法律、促進因素、限制因素)
  • 最終用途產業分析
  • 全球照護現場(POC)血液凝固檢驗市場:成長率分析
  • 全球照護現場(POC)血液凝固檢驗市場表現:規模與成長,2019-2024
  • 全球照護現場(POC)血液凝固檢驗市場預測:規模與成長,2024-2029 年,2034 年預測
  • 全球照護現場(POC)血液凝固檢驗總目標市場(TAM)

第6章市場區隔

  • 全球照護現場(POC)血液凝固檢驗市場(按技術、效能和預測)2019-2024 年、2024-2029 年、2034 年
  • 光學技術
  • 機械工業
  • 電化學技術
  • 全球照護現場(POC)血液凝固檢驗市場:依通路、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 直接競標
  • 零售
  • 全球照護現場(POC)血液凝固檢驗市場:依最終使用者、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 居家護理
  • 全球照護現場(POC)血液凝固檢驗市場,按光學技術細分,按類型、性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 光強度測量
  • 螢光偵測
  • 比色檢測
  • 全球照護現場(POC)血液凝固檢驗市場,按機器技術細分,按類型、性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 機械振動
  • 超音波檢測
  • 全球照護現場(POC)血液凝固檢驗市場,按電化學技術細分,按類型、性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 安培檢測
  • 電位差檢測
  • 電導率檢測

第7章 區域和國家分析

  • 全球照護現場(POC)血液凝固檢驗市場:區域、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球照護現場(POC)血液凝固檢驗市場:國家、績效及預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章競爭格局與公司概況

  • 照護現場(POC)血液凝固檢驗市場:競爭格局
  • 照護現場(POC)血液凝固檢驗市場:公司簡介
    • AT&T Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Danaher Corporation
  • Medtronic Plc
  • Koninklijke Philips NV
  • Sysmex Corporation
  • IDEXX Laboratories Inc.
  • Quidel Corporation
  • Bio-Rad Laboratories Inc.
  • Teleflex Incorporated
  • Werfen SA
  • Nihon Kohden Corporation
  • Horiba Ltd.
  • Hycel
  • Nova Biomedical Corporation
  • Haemonetics Corporation
  • Maccura Biotechnology Co. Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029 年照護現場(POC)血液凝固檢驗市場:提供新機會的國家
  • 2029 年照護現場(POC)血液凝固檢驗市場:細分市場將帶來新機會
  • 2029 年照護現場(POC)血液凝固檢驗市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r28769

Point-of-care (POC) coagulation testing is a diagnostic method that evaluates blood clotting function at or near the patient's location, rather than in a centralized lab. It provides rapid results, typically within minutes, enabling healthcare professionals to make timely treatment decisions and optimize anticoagulation therapy.

The main technologies used in POC coagulation testing are optical, mechanical, and electrochemical. Optical technology utilizes light for various applications, including data transfer, imaging, and sensing. These tests are distributed through channels such as direct tenders and retail to end-users such as hospitals, clinics, and home care settings.

The point-of-care (POC) coagulation testing market research report is one of a series of new reports from The Business Research Company that provides point-of-care (POC) coagulation testing market statistics, including point-of-care (POC) coagulation testing industry global market size, regional shares, competitors with a point-of-care (POC) coagulation testing market share, detailed point-of-care (POC) coagulation testing market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care (POC) coagulation testing industry. This point-of-care (POC) coagulation testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care (POC) coagulation testing market size has grown strongly in recent years. It will grow from $1.18 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rise in patient demand, growing trend of point-of-care testing, high reliability of coagulation status on pt test, automation and integration with electronic health records (EHRs), rising incidence of cardiovascular diseases and blood disorders.

The point-of-care (POC) coagulation testing market size is expected to see steady growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to expanding applications in healthcare, rising demand in homecare settings, increased prevalence of chronic blood disorders, patient demand for rapid and accurate testing, rise in point-of-care testing. Major trends in the forecast period include technological advancements, high demand in developed countries, expanding applications in healthcare, COVID-19 impact, multiplexing POC diagnostics.

The point-of-care (POC) coagulation testing market is expected to grow due to the increasing incidence of cardiovascular diseases (CVDs). CVDs encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease and cerebrovascular disease. POC coagulation testing plays a crucial role in CVD treatment by providing real-time information on coagulation status, enabling timely interventions and reducing the risk of bleeding complications, particularly after cardiac surgery. For example, in May 2023, the Centers for Disease Control and Prevention reported that heart disease claimed about 695,000 lives in the United States in 2021, accounting for 1 in 5 deaths. Coronary heart disease, the most common type, caused 375,476 deaths in 2021. This increasing prevalence of cardiovascular diseases is a key driver behind the growth of the POC coagulation testing market.

Major companies in the point-of-care (POC) coagulation testing market are concentrating on strategic collaborations to enhance their competitive position. These collaborations involve formal agreements between two or more parties to work towards specific, mutually beneficial goals. For example, in October 2021, Trivitron Healthcare partnered with Diagon Ltd. and Vanguard Diagnostics to introduce Coagulation Analyzer products. These analyzers offer precise and efficient coagulation testing, with the collaboration aimed at enhancing patient diagnosis and management. The range of analyzers is designed to cater to various healthcare settings, making coagulation testing more accessible.

In December 2023, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx Ltd. for $350 million. This acquisition enhances Roche's diagnostics portfolio, enabling more patient-centric healthcare through point-of-care solutions that cover the entire patient journey. LumiraDx Ltd., based in the UK, specializes in point-of-care coagulation testing.

Major companies operating in the point-of-care (POC) coagulation testing market report are AT&T Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Medtronic Plc, Koninklijke Philips N.V., Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Teleflex Incorporated, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc

North America was the largest region in the point-of-care (POC) coagulation testing market in 2024. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care (poc) coagulation testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care (POC) coagulation testing market consists of revenues earned by entities by providing coagulation testing services, on-site hemostasis testing, point-of-care diagnostic services, and rapid coagulation analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care (POC) coagulation testing market also includes sales of coagulation analyzers, test strips, prothrombin time (PT) monitors, D-dimer testing devices, and point-of-care coagulation testing kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-of-Care (POC) Coagulation Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care (poc) coagulation testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care (poc) coagulation testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care (poc) coagulation testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Optical Technology; Mechanical Technology; Electrochemical Technology
  • 2) By Distribution Channel: Direct Tenders; Retail
  • 3) By End-User: Hospitals; Clinics; Home care
  • Subsegments:
  • 1) By Optical Technology: Reflectance Photometry; Fluorescence Detection; Colorimetric Detection
  • 2) By Mechanical Technology: Mechanical Oscillation; Ultrasonic Detection
  • 3) By Electrochemical Technology: Amperometric Detection; Potentiometric Detection; Conductometric Detection
  • Companies Mentioned: AT&T Corporation; Siemens Healthcare GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-of-Care (POC) Coagulation Testing Market Characteristics

3. Point-of-Care (POC) Coagulation Testing Market Trends And Strategies

4. Point-of-Care (POC) Coagulation Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Point-of-Care (POC) Coagulation Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point-of-Care (POC) Coagulation Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point-of-Care (POC) Coagulation Testing Market Growth Rate Analysis
  • 5.4. Global Point-of-Care (POC) Coagulation Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point-of-Care (POC) Coagulation Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point-of-Care (POC) Coagulation Testing Total Addressable Market (TAM)

6. Point-of-Care (POC) Coagulation Testing Market Segmentation

  • 6.1. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Optical Technology
  • Mechanical Technology
  • Electrochemical Technology
  • 6.2. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Tenders
  • Retail
  • 6.3. Global Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home care
  • 6.4. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Optical Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reflectance Photometry
  • Fluorescence Detection
  • Colorimetric Detection
  • 6.5. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Mechanical Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Oscillation
  • Ultrasonic Detection
  • 6.6. Global Point-of-Care (POC) Coagulation Testing Market, Sub-Segmentation Of Electrochemical Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Amperometric Detection
  • Potentiometric Detection
  • Conductometric Detection

7. Point-of-Care (POC) Coagulation Testing Market Regional And Country Analysis

  • 7.1. Global Point-of-Care (POC) Coagulation Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point-of-Care (POC) Coagulation Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market

  • 8.1. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point-of-Care (POC) Coagulation Testing Market

  • 9.1. China Point-of-Care (POC) Coagulation Testing Market Overview
  • 9.2. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point-of-Care (POC) Coagulation Testing Market

  • 10.1. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point-of-Care (POC) Coagulation Testing Market

  • 11.1. Japan Point-of-Care (POC) Coagulation Testing Market Overview
  • 11.2. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point-of-Care (POC) Coagulation Testing Market

  • 12.1. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point-of-Care (POC) Coagulation Testing Market

  • 13.1. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point-of-Care (POC) Coagulation Testing Market

  • 14.1. South Korea Point-of-Care (POC) Coagulation Testing Market Overview
  • 14.2. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point-of-Care (POC) Coagulation Testing Market

  • 15.1. Western Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • 15.2. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point-of-Care (POC) Coagulation Testing Market

  • 16.1. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point-of-Care (POC) Coagulation Testing Market

  • 17.1. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point-of-Care (POC) Coagulation Testing Market

  • 18.1. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point-of-Care (POC) Coagulation Testing Market

  • 19.1. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point-of-Care (POC) Coagulation Testing Market

  • 20.1. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point-of-Care (POC) Coagulation Testing Market

  • 21.1. Eastern Europe Point-of-Care (POC) Coagulation Testing Market Overview
  • 21.2. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point-of-Care (POC) Coagulation Testing Market

  • 22.1. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point-of-Care (POC) Coagulation Testing Market

  • 23.1. North America Point-of-Care (POC) Coagulation Testing Market Overview
  • 23.2. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point-of-Care (POC) Coagulation Testing Market

  • 24.1. USA Point-of-Care (POC) Coagulation Testing Market Overview
  • 24.2. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point-of-Care (POC) Coagulation Testing Market

  • 25.1. Canada Point-of-Care (POC) Coagulation Testing Market Overview
  • 25.2. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point-of-Care (POC) Coagulation Testing Market

  • 26.1. South America Point-of-Care (POC) Coagulation Testing Market Overview
  • 26.2. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point-of-Care (POC) Coagulation Testing Market

  • 27.1. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point-of-Care (POC) Coagulation Testing Market

  • 28.1. Middle East Point-of-Care (POC) Coagulation Testing Market Overview
  • 28.2. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point-of-Care (POC) Coagulation Testing Market

  • 29.1. Africa Point-of-Care (POC) Coagulation Testing Market Overview
  • 29.2. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point-of-Care (POC) Coagulation Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape And Company Profiles

  • 30.1. Point-of-Care (POC) Coagulation Testing Market Competitive Landscape
  • 30.2. Point-of-Care (POC) Coagulation Testing Market Company Profiles
    • 30.2.1. AT&T Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Point-of-Care (POC) Coagulation Testing Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Medtronic Plc
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Sysmex Corporation
  • 31.5. IDEXX Laboratories Inc.
  • 31.6. Quidel Corporation
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Teleflex Incorporated
  • 31.9. Werfen SA
  • 31.10. Nihon Kohden Corporation
  • 31.11. Horiba Ltd.
  • 31.12. Hycel
  • 31.13. Nova Biomedical Corporation
  • 31.14. Haemonetics Corporation
  • 31.15. Maccura Biotechnology Co. Ltd.

32. Global Point-of-Care (POC) Coagulation Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point-of-Care (POC) Coagulation Testing Market

34. Recent Developments In The Point-of-Care (POC) Coagulation Testing Market

35. Point-of-Care (POC) Coagulation Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Point-of-Care (POC) Coagulation Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point-of-Care (POC) Coagulation Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point-of-Care (POC) Coagulation Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer